Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EBT (2020 - 2025)

iSpecimen (ISPC) has 6 years of EBT data on record, last reported at -$2.8 million in Q3 2025.

  • For Q3 2025, EBT fell 65.34% year-over-year to -$2.8 million; the TTM value through Sep 2025 reached -$12.3 million, down 26.75%, while the annual FY2024 figure was -$12.9 million, 18.55% down from the prior year.
  • EBT reached -$2.8 million in Q3 2025 per ISPC's latest filing, down from -$1.8 million in the prior quarter.
  • Across five years, EBT topped out at $30538.0 in Q4 2021 and bottomed at -$6.0 million in Q4 2024.
  • Average EBT over 5 years is -$2.4 million, with a median of -$2.2 million recorded in 2024.
  • Peak YoY movement for EBT: skyrocketed 103.27% in 2021, then crashed 7172.11% in 2022.
  • A 5-year view of EBT shows it stood at $30538.0 in 2021, then plummeted by 7172.11% to -$2.2 million in 2022, then plummeted by 30.96% to -$2.8 million in 2023, then plummeted by 111.96% to -$6.0 million in 2024, then surged by 52.79% to -$2.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$2.8 million in Q3 2025, -$1.8 million in Q2 2025, and -$1.6 million in Q1 2025.